Have to reiterate my previous comments on Darryl Ellis. I'm very...

Have to reiterate my previous comments on Darryl Ellis. I'm very impressed at the efficiency and speed in which He has put MLA onto the right track IMO. Cost management, acquisition of new sales staff, realigning the product base (equine offerings), embedding Medivet and squeezing more out perceived 'stale' businesses (clements).

The Half year report reads incredibly well, and all the metrics seem to be tracking in the right direction (and quickly!). Thoroughly looking forward to the next quarterly update to see the growth continue. I feel the only mixed blessing is the tightly held register, which when the price is right should loosen up slightly.

I'm fully backing your projections Groberts. I'm hoping for FY revenue of just under $17m, achievable with quarterly rev of approx 4.5m each of the remaining quarters. Given MLAs margins, that could result in a profit around 800k-1m (excl any one-offs).

Overall incredibly pleased I doubled up sub 8c, would like to see an updated top 20 holding too, I guess I'll have to wait 6mths for that.